Richard A. Fair insider trades

Open-market stock purchases and sales by Richard A. Fair, PRESIDENT AND CEO at Enliven Therapeutics, Inc, from SEC Form 4 filings since Jan 30, 2017.

Recent trades

DateStockTradeValue
Dec 11, 2025ELVN Enliven Therapeutics, IncBought (not open market)—

Companies traded

  • ELVN Enliven Therapeutics, Inc: other filings, last Dec 11, 2025
  • BLCM Bellicum Pharmaceuticals, Inc: 3 buys, last Aug 15, 2022
  • CLVS Clovis Oncology, Inc: other filings, last Jun 10, 2021

Get free alerts when Richard A. Fair files a new trade →